Launch week offerEnds in00h00m00s

Bruce Russell

Has grant

Professor of Parasitology

University of Otago
Country flagNew Zealand

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Dr. Bruce Russell is an Associate Professor at the University of Otago, New Zealand. His research focuses on the functional and immunological mapping of malaria-related proteins, gastrointestinal microbiome interactions, and the pharmacological profiles of novel antimalarial compounds. He has contributed significantly to the understanding of erythrocyte tropism in malaria and the genetic diversity of Plasmodium vivax . His recent articles reflect an extensive study on malaria mechanisms, emphasizing the importance of both host-parasite interactions and microbiome dynamics.

Recent Grants

Grant: Close

Leveraging neuropharmacology to target trap-shy and bait-shy vertebrate pests

Open Date: 2022-10-01

Close Date: 2025-09-30

Grant: Close

Walking backwards into the future: An evolutionary investigation into the high rates of metabolic disease in Pacific populations

Open Date: 2020-01-01

Close Date: 2023-01-01

Grant: Close

Unraveling the molecular basis for vivax malaria's unhealthy attraction to human reticulocytes

Open Date: 2018-01-01

Close Date: 2021-01-01

Grant: Close

Genetic and molecular basis of drug resistance and drug action in vivax malaria

Open Date: 2017-01-01

Close Date: 2020-10-01

Grant: Close

Plasmodium vivax culutre and its application to understanding the biology of chloroquine resistance

Open Date: 2005-01-01

Close Date: 2006-12-31

Articles (16)

Year:

2026

Year:

2025

Testing Plasmodium vivax antimicrobial sensitivity is limited to ex vivo schizont maturation assays, which preclude determining the IC50s of delayed action antimalarials such as doxycycline. Using Plasmodium cynomolgi as a model for P. vivax , we determined the physiologically significant delayed death effect induced by doxycycline [IC 50(96 h) , 1,401 ± 607 nM]. As expected, IC 50(96 h) to chloroquine (20.4 nM), piperaquine (12.6 µM), and tafenoquine (1,424 nM) were not affected by extended exposure.

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (13)

Sergio Romeo

Associate Professor

Università degli Studi di Torino

ITALY
View details

Donatella Taramelli

Full Professor of Pathology

University of Milan

ITALY
View details

SILVIA PARAPINI

Associate Professor in Biotechnology and Methods in Laboratory Medicine

University of Milan

ITALY
View details

Sarah Auburn

-

AUSTRALIA
View details

Benoit Malleret

Assistant Professor

National University of Singapore (NUS)

SINGAPORE
View details

Laurent Renia

Professor of Infectious Diseases

Lee Kong Chian School of Medicine, Nanyang Technological University

SINGAPORE
View details

Daniel Pletzer

Associate Professor

University of Otago

NEW ZEALAND
View details

Anna Sparatore

Full Professor

Università degli Studi di Torino

ITALY
View details

Osamu Kaneko

Dean

Institute of Tropical Medicine, Nagasaki University

JAPAN
View details

Annelise E. Barron

Associate Professor

Stanford University

UNITED STATES
View details

Gabriela Minigo

Charles Darwin University

AUSTRALIA
View details

Giulio Dondio

Contract Professor

University of Pavia

ITALY
View details

Wenn-Chyau Lee

Senior Lecturer

University of Malaya

MALAYSIA
View details